LF 984
Latest Information Update: 30 Mar 2001
At a glance
- Originator Groupe Fournier
- Class
- Mechanism of Action Transforming growth factor beta inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Fibrosis
Most Recent Events
- 30 Mar 2001 Discontinued-Preclinical for Fibrosis in France (Unknown route)
- 29 Dec 1999 LF 984 is available for licensing (http://www.groupe-fournier.com/)
- 15 Nov 1999 Preclinical development for Fibrosis in France (Unknown route)